Quantcast
Last updated on April 19, 2014 at 17:21 EDT

Latest zinc deficiency Stories

2011-04-11 00:00:36

China's National Agro-Tech Extension Service Center (NATESC), part of the Ministry of Agriculture (MOA), and the International Zinc Association (IZA) have launched a cooperative project to study and promote zinc fertilizer use in Chinese agriculture. The main objective of the project is to include zinc as a fertilizer nutrient in the nationwide fertilizer recommendations in order to increase crop production, crop nutritional value and water-use efficiency. The project specifically recognizes...

2011-01-18 05:00:00

ANN ARBOR, Mich., Jan. 18, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (Amex: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that it will host an Alzheimer's disease-focused Investor Day on Tuesday, February 8, 2011 from 3:00-5:00 P.M. (EST) at the Kensington Court Hotel in Ann Arbor, Michigan. Headquartered in Ann Arbor, Adeona's management team welcomes shareholders, potential investors and interested parties to join them for...

2010-12-16 05:00:00

ANN ARBOR, Mich., Dec. 16, 2010 /PRNewswire-FirstCall/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that it has acquired access to clinical data supporting a zinc-based therapy for the prevention of infections in the elderly. This acquisition expands and enhances Adeona's zinc-based product candidate portfolio that already includes its proprietary zinc-based tablets for use in the...

2010-10-12 05:00:00

ANN ARBOR, Mich., Oct. 12 /PRNewswire/ -- Adeona Pharmaceuticals, Inc., (Amex: AEN) announced five scientific publications on the role of copper toxicity and zinc deficiency in Alzheimer's disease and cognitive decline. The author of all these publications is Adeona's scientific founder and consultant, George J. Brewer, M.D., the Morton S. and Henrietta Sellner Emeritus Professor of Human Genetics and Internal Medicine at the University of Michigan. The first two publications describe the...

2010-10-06 05:00:00

ANN ARBOR, Mich., Oct. 6 /PRNewswire-FirstCall/ -- Adeona Pharmaceuticals, Inc., (Amex: AEN) announced completion of 100% enrollment in Part 2 of its clinical study, A Prospective, Randomized, Double Blind Trial of a Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease (CopperProof-2). Part 2 of the CopperProof-2 study is designed as a 60-subject comparator study. Alzheimer's disease and mild cognitive impairment subjects are randomized on a 50:50 basis to receive either...

2010-07-06 05:00:00

ANN ARBOR, Mich., July 6 /PRNewswire-FirstCall/ -- Adeona Pharmaceuticals, Inc., (AMEX: AEN) announced today that on July 6, 2010, it completed an equity financing of $1 million with a single institutional investor, Seaside 88, L.P. The financing involved the sale of 1,212,121 registered shares of common stock and no warrants. Enclave Capital served as placement agent and will receive a 7% cash commission and 5-year warrants to acquire 60,606 shares of Adeona at $1.32 per share. The use...

2010-06-07 05:00:00

ANN ARBOR, Mich., June 7 /PRNewswire-FirstCall/ -- Adeona Pharmaceuticals, Inc. (Amex: AEN) announced the completion of 50% enrollment in Part 2 of its clinical study, A Prospective, Randomized, Double Blind Trial of a Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease (CopperProof-2). The CopperProof-2 study represents the first controlled clinical study of oral zinc cysteine for the dietary management of Alzheimer's disease and mild cognitive impairment. Part 2 of the...

2009-11-03 14:31:35

Press release from PLoS Medicine In a study assessing the impact of the first national campaign to scale up zinc treatment of diarrhea in Bangladesh, researchers found that awareness was high but usage lagged behind. In this week's open access journal PLoS Medicine, Charles Larson and colleagues from International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) report the results of seven repeated ecologic surveys in four areas in Bangladesh, representing 1.5 million children...

2009-08-30 13:05:59

Scientists have developed a new molecular sensor that can reveal the amount of zinc in cells, which could tell us more about a number of diseases, including type 2 diabetes. The research, published today in Nature Methods, opens the door to the hidden world of zinc biology by giving scientists an accurate way of measuring the concentration of zinc and its location in cells for the first time. Zinc is involved in many processes in the body and five percent of all the proteins made by the...

2009-05-05 17:42:26

Researchers in India suggest zinc supplements may be no more effective than a placebo in treating diarrhea in children. The randomized controlled trial of zinc and zinc and copper supplements, published in BMC Medicine, involved a group of 808 children in Nagpur, India. The expected beneficial effects of zinc supplementation for acute diarrhea were not observed, study leader Archana Patel of the Lata Medical Research Foundation said in a statement. Therapeutic zinc or zinc and copper...